Bottom line
SHPCX vs IBBQ: the short answer
SHPCX (Health & Biotechnology Portfolio) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both mutual funds.
But IBBQ is far broader, holding 261 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.
IBBQ is cheaper at 0.19% vs 3.6% — a difference of $341 a year per $10,000 invested.
Over one year, IBBQ returned −0.6% vs −1.3% for SHPCX.
Updated Nov 19, 2026
SHPCX vs IBBQ side by side
| SHPCX | IBBQ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Saratoga Advantage | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 3.6% | 0.19% |
| Annual cost per $10k | $360 | $19 |
| 10-yr cost on $10k (prospectus) | $3,862 | $242 |
| Max front load | 0% | None |
| 12b-1 fee | — | — |
| 1-yr return | −1.3% | −0.6% |
| 5-yr return (annualized) | +3.7% | — |
| 10-yr return (annualized) | +4.1% | — |
| Best quarter | +15.0% | +12.0% |
| Worst quarter | −13.0% | −11.7% |
| Net assets (fund) | $10.5M | $67.4M |
| Number of holdings | 29 | 261 |
| Portfolio turnover | 22% | 17% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHPCX | IBBQ | Difference |
|---|---|---|---|
| 2024 | −0.3% | −0.6% | +0.3% |
| 2023 | −0.9% | +4.5% | −5.4% |
| 2022 | +1.4% | −10.2% | +11.7% |
Source: Fund prospectus bar charts
Holdings overlap
8 of SHPCX's top 25 holdings also appear in IBBQ's top 25.
| Holding | SHPCX | IBBQ |
|---|---|---|
| Jazz Pharmaceuticals Plc | 6.19% | 1.16% |
| United Therapeutics Corp | 6.17% | 1.94% |
| Amgen Inc | 5.04% | 7.10% |
| Exelixis Inc | 4.55% | 1.04% |
| Gilead Sciences Inc | 3.94% | 7.39% |
| Regeneron Pharmaceuticals Inc | 3.93% | 5.08% |
| Vertex Pharmaceuticals Inc | 3.36% | 7.38% |
| Incyte Corp | 2.89% | 1.53% |
Source: SEC Form N-PORT
SHPCX top 10
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
FAQ
What is the difference between SHPCX and IBBQ?
Which is cheaper, SHPCX or IBBQ?
Should I own both SHPCX and IBBQ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.